Minerva Neurosciences (NERV) Non-Current Assets (2013 - 2026)

Minerva Neurosciences posted quarterly Non-Current Assets of $14.9 million for Q1 2026, little changed year-on-year from $14.9 million in Q1 2025, and little changed on a QoQ basis from $14.9 million in Q4 2025.

Minerva Neurosciences (NERV) has 14 years of Non-Current Assets data on file, last reported at $14.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets changed 0.32% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2026 stood at $59.7 million (changed 0.38% YoY), and the FY2025 full-year result was $14.9 million, changed 0.04% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $14.9 million, roughly flat from $14.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $15.1 million in Q3 2025 and bottomed at $14.9 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $14.9 million (2023), against an average of $14.9 million.
  • The widest annual swing landed in 2022, when Non-Current Assets sank 50.5%; it then rose 1.32% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $14.9 million in 2022, then dropped by 0.21% to $14.9 million in 2023, then decreased by 0.15% to $14.9 million in 2024, then decreased by 0.04% to $14.9 million in 2025, then rose by 0.34% to $14.9 million in 2026.
  • The last three Non-Current Assets figures came in at $14.9 million (Q1 2026), $14.9 million (Q4 2025), and $15.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn - 14.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.92 Mn
Dec 31, 2025 14.87 Mn
Sep 30, 2025 15.07 Mn
Jun 30, 2025 14.87 Mn
Mar 31, 2025 14.87 Mn
Dec 31, 2024 14.87 Mn
Sep 30, 2024 14.88 Mn
Jun 30, 2024 14.88 Mn
Mar 31, 2024 14.89 Mn
Dec 31, 2023 14.90 Mn
Sep 30, 2023 14.91 Mn
Jun 30, 2023 14.91 Mn
Mar 31, 2023 14.92 Mn
Dec 31, 2022 14.93 Mn
Sep 30, 2022 14.92 Mn
Jun 30, 2022 14.92 Mn
Mar 31, 2022 14.92 Mn
Dec 31, 2021 14.92 Mn
Sep 30, 2021 30.12 Mn
Jun 30, 2021 30.10 Mn
Mar 31, 2021 30.14 Mn
Dec 31, 2020 30.19 Mn
Sep 30, 2020 30.23 Mn
Jun 30, 2020 30.28 Mn
Mar 31, 2020 30.32 Mn
Dec 31, 2019 30.36 Mn
Sep 30, 2019 49.40 Mn
Jun 30, 2019 49.44 Mn
Mar 31, 2019 49.48 Mn
Dec 31, 2018 49.12 Mn
Sep 30, 2018 49.12 Mn
Jun 30, 2018 49.13 Mn
Mar 31, 2018 49.13 Mn
Dec 31, 2017 54.16 Mn
Sep 30, 2017 59.42 Mn
Jun 30, 2017 49.31 Mn
Mar 31, 2017 49.08 Mn
Dec 31, 2016 49.08 Mn
Sep 30, 2016 49.08 Mn
Jun 30, 2016 49.09 Mn
Mar 31, 2016 49.09 Mn
Dec 31, 2015 49.10 Mn
Sep 30, 2015 50.51 Mn
Jun 30, 2015 58.55 Mn
Mar 31, 2015 49.10 Mn
Dec 31, 2014 49.11 Mn
Sep 30, 2014 49.10 Mn
Jun 30, 2014 52.44 Mn
Dec 31, 2013 27.36 Mn